Busulfan is a strong medicine used to treat certain types of cancer, like leukemia. It works by stopping the bone marrow from making new blood cells. It's used to help manage symptoms but doesn't usually cure the cancer.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Busulfan is a chemotherapy medicine used mainly to prepare people for a stem cell transplant, often called a bone marrow transplant. It comes in two forms that are used in very different ways. Busulfex, and generic busulfan injection, is given intravenously at high doses as part of conditioning: treatment that clears out a person's own bone marrow, including leukemia cells, so that donor stem cells can take its place. Its FDA approval is for use with another chemotherapy drug, cyclophosphamide, before a transplant from a donor (an allogeneic transplant) for chronic myeloid leukemia (CML), a slow-growing cancer of the white blood cells. Beyond that approval, transplant centers widely use IV busulfan, often paired with fludarabine or cyclophosphamide, before donor transplants for other blood cancers such as acute myeloid leukemia. It can also serve as the conditioning step before some gene therapies, such as Casgevy for sickle cell disease and beta thalassemia. Myleran is an oral tablet taken at much lower doses to control CML. It eases the disease but does not cure it. For most people with CML today, the main treatment is a targeted pill called a tyrosine kinase inhibitor (TKI), and a donor transplant is considered when TKIs do not keep the disease under control.
Busulfan belongs to a group of chemotherapy drugs called alkylating agents. In the body it forms reactive molecules that attach to DNA and damage it, which stops cells from dividing normally. Cells that divide often, such as the blood-forming stem cells in the bone marrow and leukemia cells, are hit hardest. That effect on the marrow is the reason busulfan is used. At transplant doses it suppresses the marrow so deeply and for so long that the body cannot safely recover on its own, which is why a stem cell infusion always follows. The infused cells settle in the empty marrow and begin making new blood cells, a process called engraftment. At the low doses in Myleran tablets, the same action gradually brings down the excess white blood cells that CML produces.
IV busulfan is given in a hospital or transplant unit through a central line, a thin tube placed in a large vein. In the schedule on the US label, each dose runs over two hours and is repeated every six hours for four days, for 16 doses in total, followed by cyclophosphamide and then the stem cell infusion a few days later. Other regimens pair busulfan with different drugs and timing. The dose is based on body weight, and because people clear busulfan from the blood at different rates, many teams measure blood levels after the first dose and adjust later doses toward a target. Getting that exposure right matters: in studies, higher exposure has been linked to more liver complications, and in children, lower exposure to a greater chance that the new cells fail to take hold. High-dose busulfan can cause seizures, so people receive anti-seizure medicine starting before the first dose and continuing until a day after the last one, along with anti-nausea medicine on a fixed schedule. Tell the team about any history of seizures or head injury. Myleran tablets are taken by mouth once a day, with the dose guided by regular blood counts rather than a fixed plan. White blood cell counts may not start falling for 10 to 15 days, and they keep falling for weeks after the tablets stop, so the prescriber usually stops the drug before counts reach the normal range and restarts it if they climb again. Because it is an anticancer drug, ask the pharmacist how to handle and dispose of the tablets.
During transplant conditioning, side effects are nearly universal. Nausea, vomiting, painful mouth sores (mucositis), loss of appetite, diarrhea, trouble sleeping, anxiety, headache, fever and rash are all common, as are low magnesium and potassium and high blood sugar, which the team checks and corrects. The central effect is the drop in blood counts. In the first weeks after transplant, white cells, platelets and red cells are very low, bringing a high risk of infection, bleeding and fatigue. People receive transfusions, antibiotics and other support until the new marrow starts working, which in the main busulfan study took about two weeks. A fever during this time should be reported to the transplant team right away. Veno-occlusive disease (VOD), also called sinusoidal obstruction syndrome, is one of the most serious early complications. Small blood vessels in the liver become blocked and the liver is damaged. It occurred in about 8 to 12 percent of people in studies and can be fatal, which is why liver blood tests are checked daily through the first four weeks after transplant. With oral Myleran, the main risk is blood counts falling too far, which can lead to infection or bleeding and, in some cases, marrow suppression that lasts months. Skin darkening is the most common skin effect, and women who have not reached menopause often have missed periods and menopause-like symptoms. Rarely, long-term use causes a condition resembling adrenal insufficiency, with weakness, severe fatigue, weight loss and nausea. Months or even years after busulfan, a new cough, shortness of breath or low-grade fever can be a sign of lung scarring known as busulfan lung. It is rare but serious, so these symptoms should be reported to the doctor rather than waited out.
Several medicines change how quickly the body clears busulfan, which matters because the dose is aimed at a precise level. Acetaminophen, the common pain and fever reliever, taken within three days before or during IV busulfan may raise busulfan levels. The antibiotic metronidazole and the antifungal itraconazole also raise levels, and drugs that remove excess iron from the body, such as deferasirox, should be stopped well before treatment. The anti-seizure medicine phenytoin has the opposite effect and lowers levels. With oral busulfan, long-term use together with thioguanine, another leukemia medicine, has been linked to serious liver problems. Busulfan can harm a developing baby. Women who could become pregnant should use effective contraception during treatment and for 6 months afterward, and men with partners who could become pregnant should do so for 3 months afterward. A known or suspected pregnancy should be reported to the care team, and breastfeeding should stop during treatment. Busulfan may also cause temporary or permanent infertility in both women and men, and it can prevent girls from going through puberty. Because busulfan damages DNA, it is considered a cause of later cancers, including leukemia, which can appear years after treatment.
With IV busulfan, the four days of conditioning are only the beginning. Blood counts are checked daily until the new cells engraft, and liver tests daily through the first four weeks after transplant, while the team watches for infection, liver problems and mouth sores that can make eating difficult. Recovery of the blood counts is the first milestone; the rest of the transplant course, including the risk of graft-versus-host disease when donor cells are used, depends on the transplant itself more than on busulfan. Long-term follow-up includes watching for late effects such as lung problems, changes in fertility and hormones, and second cancers. With Myleran, white blood cell counts usually take about 12 to 20 weeks of daily treatment to reach the normal range. During remission the doctor typically checks in about once a month and restarts treatment if counts rise again. Because the tablets control CML rather than cure it, it is worth understanding how this approach compares with TKI therapy or a transplant.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Busulfan, what you've noticed, or ask the community a question.